These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 16596242)
1. 18FDG PET in oncology: the best and the worst (Review). Belhocine T; Spaepen K; Dusart M; Castaigne C; Muylle K; Bourgeois P; Bourgeois D; Dierickx L; Flamen P Int J Oncol; 2006 May; 28(5):1249-61. PubMed ID: 16596242 [TBL] [Abstract][Full Text] [Related]
2. 18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer. Muylle K; Castaigne C; Flamen P Curr Opin Oncol; 2005 May; 17(3):249-53. PubMed ID: 15818169 [TBL] [Abstract][Full Text] [Related]
3. [The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases]. Ruiz Hernández G; Romero de Avila Y Avalos C; Carreras Delgado JL Med Clin (Barc); 2005 Feb; 124(6):229-36. PubMed ID: 15737307 [TBL] [Abstract][Full Text] [Related]
5. [Use of PET for evaluation of treatment response in oncology]. Bourguet P Cancer Radiother; 2006 Nov; 10(6-7):334-7. PubMed ID: 16950641 [TBL] [Abstract][Full Text] [Related]
12. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer. Pelosi E; Deandreis D Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522 [TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography: clinical applications in oncology. Part 1. Kumar R; Nadig MR; Chauhan A Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099 [TBL] [Abstract][Full Text] [Related]
14. Potential usefulness of 18F-2-fluoro-deoxy-D-glucose positron emission tomography in cervical compressive myelopathy. Baba H; Uchida K; Sadato N; Yonekura Y; Kamoto Y; Maezawa Y; Furusawa N; Abe Y Spine (Phila Pa 1976); 1999 Jul; 24(14):1449-54. PubMed ID: 10423790 [TBL] [Abstract][Full Text] [Related]
15. Utility of positron emission tomography in sarcomas. Schuetze SM Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]-fluoro-D-glucose (18FDG) in a patient with cutaneous T-cell lymphoma. Mahmood S; Martínez de Llano SR Rev Esp Med Nucl; 2007; 26(5):306. PubMed ID: 17910841 [No Abstract] [Full Text] [Related]
17. Clinical applications of positron emission tomography in sarcoma management. Quak E; van de Luijtgaarden AC; de Geus-Oei LF; van der Graaf WT; Oyen WJ Expert Rev Anticancer Ther; 2011 Feb; 11(2):195-204. PubMed ID: 21342039 [TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT in oncology: "raising the bar". Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652 [TBL] [Abstract][Full Text] [Related]